Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS
Watson Hired to Accelerate DNA-Based "GPS" Genetic Testing App Which Combines with RTGN's High-Resolution Retinal Imaging Technologies Seeking to Revolutionize Diagnosis of Systemic Diseases
PETALUMA, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the hiring of Owen Watson, MS. [Click here for full press release]
RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board (“IRB”) for research on its DNA/GPS program
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board (“IRB”) for research on its DNA/GPS program. The study aims to offer recommendations for enhancing the management of ocular injections, which have become a significant healthcare burden due to their associated complications in treating macular degeneration-related vision loss.[Click here for full press release]
RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board (“IRB”) for research on its DNA/GPS program
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board (“IRB”) for research on its DNA/GPS program. The study aims to offer recommendations for enhancing the management of ocular injections, which have become a significant healthcare burden due to their associated complications in treating macular degeneration-related vision loss.[Click here for full press release]
PETALUMA, Calif., July 06, 2022 -- Acquisition of DNA-Based "GPS" Genetic Testing Combines with RTGN's High Resolution Retinal Imaging Technologies Seeks to Revolutionize Diagnosis of Systemic Diseases [click here for full press release]
RetinalGeniX™ Technologies Announces RetinalCam™ a Home Monitoring & Physician Alert System
PETALUMA, Calif., October 27, 2020 -- The First In-Home Self-Monitoring Physician Visual Alert Device with Real-Time Imaging of the Central Retina Including Streaming Video to the Physician! [click here for full press release]
RetinalGeniX™ Technologies Selects OPTIONTRAX for Equity Management
PETALUMA, Calif., Oct. 21, 2020 /PRNewswire/ -- RetinalGeniX™ Technologies, Inc. https://retinalgenix.com/ announced today that it has awarded a contract to Plan Management Corporation (PMC) for use of their OPTIONTRAX Equity Plan and Cap Table Software. RetinalGeniX™ Technologies is a private California-based medical technology company focused on prevention of blindness through mass medical retinal screening and patient home monitoring. [click here for full press release]
ADM Tronics to Develop Patented, Next-Generation Ophthalmic Diagnostic System for RetinalGeniX Technologies, Inc.
Northvale, NJ, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced that RetinalGeniX Technologies, Inc. (“RTI”), has entered into an engineering development agreement for ADMT to develop and manufacture RTI’s patented, next-generation ophthalmic diagnostic technology known as the RetinalGeniX™ system. [click here for full press release]
RetinalgeniX Technologies Inc. Plans to Treat Blindness Due to Diabetic Maculopathy
Petaluma, CA, Dec. 20, 2019 -- RetinalgeniX™ Technologies Inc. announced today its plans to spearhead an effective technology to aid in the treatment of blindness due to Diabetic Maculopathy worldwide. [click here for full press release]